Cwm LLC Has $165,000 Holdings in Doximity, Inc. (NASDAQ:DOCS)

Cwm LLC decreased its holdings in Doximity, Inc. (NASDAQ:DOCS) by 24.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,782 shares of the company’s stock after selling 1,240 shares during the period. Cwm LLC’s holdings in Doximity were worth $165,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the stock. LRI Investments LLC acquired a new position in Doximity in the 1st quarter valued at approximately $27,000. Blue Trust Inc. boosted its stake in shares of Doximity by 621.4% during the 2nd quarter. Blue Trust Inc. now owns 1,385 shares of the company’s stock valued at $37,000 after buying an additional 1,193 shares during the period. GAMMA Investing LLC grew its holdings in shares of Doximity by 40.1% during the 3rd quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock valued at $63,000 after acquiring an additional 412 shares in the last quarter. Quarry LP increased its stake in shares of Doximity by 101.2% in the second quarter. Quarry LP now owns 1,616 shares of the company’s stock worth $45,000 after acquiring an additional 131,253 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale purchased a new stake in shares of Doximity during the first quarter worth $46,000. 87.19% of the stock is owned by hedge funds and other institutional investors.

Doximity Trading Down 1.8 %

Shares of Doximity stock opened at $41.41 on Thursday. The firm has a fifty day simple moving average of $39.75 and a 200-day simple moving average of $31.53. The stock has a market capitalization of $7.68 billion, a price-to-earnings ratio of 57.51, a PEG ratio of 5.29 and a beta of 1.29. Doximity, Inc. has a 1-year low of $19.89 and a 1-year high of $44.88.

Doximity (NASDAQ:DOCS) last released its earnings results on Thursday, August 8th. The company reported $0.22 earnings per share for the quarter, topping analysts’ consensus estimates of $0.16 by $0.06. Doximity had a net margin of 32.53% and a return on equity of 19.26%. The firm had revenue of $126.68 million during the quarter, compared to analyst estimates of $119.88 million. As a group, research analysts predict that Doximity, Inc. will post 0.8 earnings per share for the current year.

Wall Street Analyst Weigh In

DOCS has been the topic of a number of recent research reports. Baird R W upgraded Doximity to a “strong-buy” rating in a research note on Tuesday, September 17th. Canaccord Genuity Group lifted their price target on Doximity from $37.00 to $40.00 and gave the company a “buy” rating in a report on Tuesday, August 20th. Truist Financial restated a “hold” rating and issued a $35.00 price objective (up previously from $31.00) on shares of Doximity in a report on Wednesday, August 14th. Needham & Company LLC upgraded shares of Doximity from a “hold” rating to a “buy” rating and set a $38.00 target price for the company in a research note on Friday, August 9th. Finally, Evercore ISI boosted their target price on shares of Doximity from $34.00 to $45.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating, five have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Doximity presently has a consensus rating of “Hold” and a consensus target price of $35.83.

Insider Buying and Selling

In other Doximity news, Director Kira Scherer Wampler sold 2,500 shares of the firm’s stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $28.18, for a total value of $70,450.00. Following the sale, the director now owns 10,258 shares of the company’s stock, valued at $289,070.44. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. In other Doximity news, Director Kira Scherer Wampler sold 2,500 shares of the stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $28.18, for a total value of $70,450.00. Following the completion of the sale, the director now directly owns 10,258 shares of the company’s stock, valued at $289,070.44. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Watkin Phoebe L. Yang sold 1,011 shares of the business’s stock in a transaction dated Monday, August 5th. The stock was sold at an average price of $25.54, for a total transaction of $25,820.94. Following the transaction, the director now owns 11,258 shares in the company, valued at approximately $287,529.32. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 35,451 shares of company stock valued at $1,201,018. Insiders own 39.40% of the company’s stock.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.